General Information of the Compound
| Compound ID |
CP0188400
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-1,3-dimethylpurino[7,8-a]pyrimidine-2,4,8-trione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H28ClN7O3
|
||||||||||||||||||
| Molecular Weight |
497.987
|
||||||||||||||||||
| Canonical SMILES |
Cn1c2nc3n(CCCCN4CCN(CC4)c4ccc(Cl)cc4)c(=O)ccn3c2c(=O)n(C)c1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H28ClN7O3/c1-27-21-20(22(34)28(2)24(27)35)32-12-9-19(33)31(23(32)26-21)11-4-3-10-29-13-15-30(16-14-29)18-7-5-17(25)6-8-18/h5-9,12H,3-4,10-11,13-16H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
HISOESWRZZNGEY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor